2026 NPPES data Ophthalmology Physician NPI 1902006539 MD, PHARMD
Verify on CMS →

SARA MAHONY, MD, PHARMD

Ophthalmology Physician in CHARLTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 524 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
97.0218/100
▲ 14 pts above national avg 83.1 · [object Object]
Industry payments
$111.02
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SARA MAHONY, MD, PHARMD reported a CMS MIPS final score of 97.0218/100 — above the 83.1 national average — and filed 2,110 Medicare Part D claims in 2023.

97.0218/100
MIPS score · +14 vs avg
2K
Part D claims, 2023
67%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SARA MAHONY, MD, PHARMD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

97 Top 15% higher than 85% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SARA MAHONY, MD, PHARMD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SARA MAHONY, MD, PHARMD?

High performer (top quartile)

NPI registry status

Active

Issued 07/22/2007

NPI 1902006539

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

2,110 49% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

97.0218/100 13.921800000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Ophthalmology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Ophthalmology Physician share within Massachusetts

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Massachusetts

Medicare quality performance — MIPS

SARA MAHONY, MD, PHARMD's 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
97.0218/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 97.0218/100 vs national avg 83.1

0%100%National avg83%97%
MIPS final score (Ophthalmology Physician) — 97.0218/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SARA MAHONY, MD, PHARMD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD, PHARMD credentials at 20 SOUTHBRIDGE RD, CHARLTON, MA, 01507, with a listed phone of (508) 765-9068. NPI 1902006539 was issued on 07/22/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAHONY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,110 prescription claims written by this provider, covering 524 Medicare beneficiaries and totaling roughly $225K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 97.0218/100 for the 2023 performance year (Quality 78.0983), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

20 SOUTHBRIDGE RD
CHARLTON, MA 01507

Provider Details

NPI 1902006539
Specialty Ophthalmology Physician
Credentials MD, PHARMD
Gender Female
NPI Issued 07/22/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

97.0218
Final Score
Avg: 83.1
78.0983
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where SARA MAHONY, MD, PHARMD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UMASS MEMORIAL MEDICAL GROUP INC
SOUTHBRIDGE, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARA MAHONY, MD, PHARMD. Source: openpaymentsdata.cms.gov.

Total received

$111

Largest payer

RxSight Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to SARA MAHONY, MD, PHARMD. To verify SARA MAHONY, MD, PHARMD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

SARA MAHONY, MD, PHARMD — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 2,110 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,110
Total Claims
$225K
Total Drug Cost
524
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,368
Total Day Supply
125,421
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$163K
Generic Drug Cost
$62K
Antibiotic Claims
15

Patient Demographics

Average Patient Age
76.0 years
Avg HCC Risk Score
1.32
Gender Split
58% female / 42% male
Age Distribution
<65: 33, 65-74: 191, 75-84: 213, 85+: 87

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SARA MAHONY, MD, PHARMD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
898
Prednisolone Acetate
299
Timolol Maleate
210
Brimonidine Tartrate
123
Dorzolamide Hcl
121
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
97
Brinzolamide
62
Lumigan
Bimatoprost
49
Erythromycin
Erythromycin Base
25
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How SARA MAHONY, MD, PHARMD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

SARA MAHONY, MD, PHARMD's 2,110 claims are above the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as MAHONY.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SARA MAHONY, MD, PHARMD's specialty?
SARA MAHONY, MD, PHARMD specializes in Ophthalmology Physician and practices in CHARLTON, Massachusetts. Credentials: MD, PHARMD.
How much does SARA MAHONY, MD, PHARMD prescribe under Medicare Part D?
In 2023, SARA MAHONY, MD, PHARMD wrote 2,110 Medicare Part D claims totaling $225K in drug costs for 524 beneficiaries.
What is SARA MAHONY, MD, PHARMD's Medicare quality score?
SARA MAHONY, MD, PHARMD has a CMS MIPS Final Score of 97.0218/100 (Quality: 78.0983). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SARA MAHONY, MD, PHARMD located?
SARA MAHONY, MD, PHARMD is located at 20 SOUTHBRIDGE RD, CHARLTON, MA, 01507. Phone: (508) 765-9068.
What is SARA MAHONY, MD, PHARMD's NPI number?
SARA MAHONY, MD, PHARMD's National Provider Identifier (NPI) is 1902006539, issued on 07/22/2007.
Does SARA MAHONY, MD, PHARMD prescribe more brand-name or generic drugs?
SARA MAHONY, MD, PHARMD's prescribing is 33% brand-name and 67% generic drugs by claim count, with $163K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does SARA MAHONY, MD, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, SARA MAHONY, MD, PHARMD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SARA MAHONY, MD, PHARMD accept Medicare?
SARA MAHONY, MD, PHARMD appears in CMS Medicare data with 2,110 Part D claims and 524 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SARA MAHONY, MD, PHARMD's credentials?
SARA MAHONY, MD, PHARMD's NPI is 1902006539 with credentials MD, PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology